Healthcare - Biotechnology - NASDAQ - GB
$ 21.79
-3.5 %
$ 1.5 B
Market Cap
-6.64
P/E
Price Target
Average
100.40%
Revenue Forecast
Estimate
98.60%
EBIT
Estimate
--21.92%
Net Income
Estimate
29.92%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Bicycle Therapeutics plc
Wall Street analysts predict an average 1-year price target for BCYC of $43.7 , with forecasts ranging from a low of $28 to a high of $55 .
BCYC Lowest Price Target
Wall Street Target
28 USD
28.50%
BCYC Average Price Target
Wall Street Target
43.7 USD
100.40%
BCYC Highest Price Target
Wall Street Target
55 USD
152.41%
REVENUE FORECAST
Revenue Forecast Chart BCYC
EBIT FORECAST
EBIT Forecast Chart BCYC
NET INCOME FORECAST
Net Income Chart BCYC